NCT06960135

Brief Summary

Background: Partial nephrectomy (PN) is a reference standard for the management of the cT1 renal mass, primarily due to better preservation of renal function. The aim of this work was to determine trifecta outcomes of open PN (OPN) and laparoscopic PN (LPN) and identify predictive factors for trifecta achievement to evaluate surgical performance, including negative surgical margins, absence of severe surgical complications, and ischemia time less than 25 minutes. Objectives: this study pointing to determine trifecta outcomes of OPN and LPN and to identify predictive factors for trifecta achievement to evaluate surgical performance, including negative surgical margins, absence of severe surgical complications, and Ischemia time less than 25 Minutes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2024

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 22, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 7, 2025

Completed
Last Updated

May 7, 2025

Status Verified

April 1, 2025

Enrollment Period

2 years

First QC Date

April 22, 2025

Last Update Submit

April 28, 2025

Conditions

Keywords

Laparoscopic, Partial NephrectomyTrifecta, Pentafecta AchievementRenal Tumors

Outcome Measures

Primary Outcomes (1)

  • Predictors of Trifecta Achievement in Open ald Laparoscopic Partial Nephrectomy for Localised Renal Tumors

    Trifecta achievement is defined as the combination of (1) negative surgical margins, (2) absence of perioperative complications classified as Clavien-Dindo grade III or higher, and (3) warm ischemia time ≤25 minutes. factors affecting trifecta achievement among variables including tumor complexity score, patient comorbidities, BMI, surgical approches, special habbites, age or gender.

    2 years

Secondary Outcomes (1)

  • Pentafecta Achivement

    2 yrs

Study Arms (2)

open partial nephrectomy

ACTIVE COMPARATOR

open partial nephrectomy

Procedure: open partial nephrectomy

laparoscopic partial nephrectomy

ACTIVE COMPARATOR

laparoscopic partial nephrectomy

Procedure: laparoscopic partial nephrectomy

Interventions

open partial nephrectomy

open partial nephrectomy

laparoscopic partial nephrectomy

laparoscopic partial nephrectomy

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who are fit for surgery.
  • Patients with renal tumor who are indicated for partial nephrectomy
  • Absolute:
  • Solitary kidney.
  • Bilateral renal tumor.
  • CDK.
  • Relative:
  • Abnormal contralateral kidney (nephropathy, nephrolithiasis, trauma).
  • Metabolic disease associated with renal failure (DM, hypertension).
  • Genetic syndrome with tumor multifocality (VHL syndrome). Elective
  • \. Clinical T1N0M0 Tumor. 2. Peripheral tumor.

You may not qualify if:

  • Patients who are unfit for surgery and who's unfit for laparoscopy.
  • Patients who are contraindicated for partial nephrectomy. As severe and irreversible coagulopathy. Patients who are indicated for radical nephrectomy (extensive tumor, metastatic tumor).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SVU hospital

Qena, Egypt, Qena Governorate, 83511, Egypt

Location

MeSH Terms

Conditions

Carcinoma, Renal Cell

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsKidney NeoplasmsUrologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesKidney DiseasesUrologic DiseasesMale Urogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer

Study Record Dates

First Submitted

April 22, 2025

First Posted

May 7, 2025

Study Start

June 1, 2022

Primary Completion

May 30, 2024

Study Completion

March 1, 2025

Last Updated

May 7, 2025

Record last verified: 2025-04

Locations